Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Guillermo Suarez-Cuartin

Showing results (21-30 of 32) with videos related to

Pageof 4
Sort By:
Thorax|July 7, 2019
Antimicrobial peptides, disease severity and exacerbations in bronchiectasisOriol Sibila, Lídia Perea, Elisabet Cantó, et al.
Frontiers in Medicine|July 19, 2021
Clinical Outcomes of Severe COVID-19 Patients Admitted to an Intermediate Respiratory Care UnitGuillermo Suarez-Cuartin, Merce Gasa, Guadalupe Bermudo, et al.
Archivos De Bronconeumologia|November 5, 2025
Systemic Immune Dysregulation in Patients With Bronchiectasis and Chronic Pseudomonas aeruginosa InfectionBelén Solarat, Núria Mendoza, Lídia Perea, et al.
American Journal of Respiratory and Critical Care Medicine|December 3, 2016
Neutrophil Elastase Activity Is Associated with Exacerbations and Lung Function Decline in BronchiectasisJames D Chalmers, Kelly L Moffitt, Guillermo Suarez-Cuartin, et al.
Annals of the American Thoracic Society|February 17, 2016
Airway Mucin 2 Is Decreased in Patients with Severe Chronic Obstructive Pulmonary Disease with Bacterial ColonizationOriol Sibila, Laia Garcia-Bellmunt, Jordi Giner, et al.
The Journal of Allergy and Clinical Immunology|May 17, 2017
Neutrophil extracellular traps are associated with disease severity and microbiota diversity in patients with chronic obstructive pulmonary diseaseAlison J Dicker, Megan L Crichton, Eleanor G Pumphrey, et al.
The European Respiratory Journal|October 19, 2023
Gastrointestinal pirfenidone adverse events in idiopathic pulmonary fibrosis depending on diet: the MADIET clinical trialMaria Molina-Molina, Jessica Germaine Shull, Vanesa Vicens-Zygmunt, et al.
The Lancet. Respiratory Medicine|February 20, 2021
Neutrophil extracellular traps, disease severity, and antibiotic response in bronchiectasis: an international, observational, multicohort studyHolly R Keir, Amelia Shoemark, Alison J Dicker, et al.
Journal of Clinical Immunology|September 27, 2021
Pre-existing Autoantibodies Neutralizing High Concentrations of Type I Interferons in Almost 10% of COVID-19 Patients Admitted to Intensive Care in BarcelonaXavier Solanich, Raúl Rigo-Bonnin, Victor-David Gumucio, et al.
Archivos De Bronconeumologia|April 25, 2021
Different Faces of Idiopathic Pulmonary Fibrosis With Preserved Forced Vital CapacityGuadalupe Bermudo, Guillermo Suarez-Cuartin, Pilar Rivera-Ortega, et al.
Pageof 4

Showing results (21-30 of 32) with videos related to

Sort By:
Pageof 4
Thorax|July 7, 2019
Antimicrobial peptides, disease severity and exacerbations in bronchiectasisOriol Sibila, Lídia Perea, Elisabet Cantó, et al.
Frontiers in Medicine|July 19, 2021
Clinical Outcomes of Severe COVID-19 Patients Admitted to an Intermediate Respiratory Care UnitGuillermo Suarez-Cuartin, Merce Gasa, Guadalupe Bermudo, et al.
Archivos De Bronconeumologia|November 5, 2025
Systemic Immune Dysregulation in Patients With Bronchiectasis and Chronic Pseudomonas aeruginosa InfectionBelén Solarat, Núria Mendoza, Lídia Perea, et al.
American Journal of Respiratory and Critical Care Medicine|December 3, 2016
Neutrophil Elastase Activity Is Associated with Exacerbations and Lung Function Decline in BronchiectasisJames D Chalmers, Kelly L Moffitt, Guillermo Suarez-Cuartin, et al.
Annals of the American Thoracic Society|February 17, 2016
Airway Mucin 2 Is Decreased in Patients with Severe Chronic Obstructive Pulmonary Disease with Bacterial ColonizationOriol Sibila, Laia Garcia-Bellmunt, Jordi Giner, et al.
The Journal of Allergy and Clinical Immunology|May 17, 2017
Neutrophil extracellular traps are associated with disease severity and microbiota diversity in patients with chronic obstructive pulmonary diseaseAlison J Dicker, Megan L Crichton, Eleanor G Pumphrey, et al.
The European Respiratory Journal|October 19, 2023
Gastrointestinal pirfenidone adverse events in idiopathic pulmonary fibrosis depending on diet: the MADIET clinical trialMaria Molina-Molina, Jessica Germaine Shull, Vanesa Vicens-Zygmunt, et al.
The Lancet. Respiratory Medicine|February 20, 2021
Neutrophil extracellular traps, disease severity, and antibiotic response in bronchiectasis: an international, observational, multicohort studyHolly R Keir, Amelia Shoemark, Alison J Dicker, et al.
Journal of Clinical Immunology|September 27, 2021
Pre-existing Autoantibodies Neutralizing High Concentrations of Type I Interferons in Almost 10% of COVID-19 Patients Admitted to Intensive Care in BarcelonaXavier Solanich, Raúl Rigo-Bonnin, Victor-David Gumucio, et al.
Archivos De Bronconeumologia|April 25, 2021
Different Faces of Idiopathic Pulmonary Fibrosis With Preserved Forced Vital CapacityGuadalupe Bermudo, Guillermo Suarez-Cuartin, Pilar Rivera-Ortega, et al.
Pageof 4